TABLE 1 .
Seroprevalence rates in cases and controls
| Pathogen | Seroprevalence cases (%) |
95% CIa | Seroprevalence controls (%) |
95% CI | Odds ratiob |
95% CI | Pd |
|---|---|---|---|---|---|---|---|
| ZIKV | 93.8 | 78.8–99.3 | 67.8 | 59.9–74.8 | 7.1c | 1.6–31.1 | 0.002 |
| CHIKV | 20.7 | 9.5–38.8 | 8.2 | 5.2–14.8 | 2.9c | 1.0–8.4 | 0.039 |
| DENV | 74.1 | 55.1–87.1 | 89.1 | 79.2–95.6 | 0.3 | 0.0–1.0 | 0.100 |
| RUBV | 90.6 | 75.0–97.5 | 97.5 | 93.5–99.2 | 0.2 | 0.0–1.2 | 0.092 |
| HSV-1 | 93.8 | 78.8–99.3 | 95.0 | 90.3–97.6 | 0.8 | 0.1–3.9 | 0.673 |
| HSV-2 | 28.1 | 15.4–45.5 | 47.1 | 32.1–47.1 | 0.6 | 0.3–1.4 | 0.230 |
| VZV | 87.5 | 71.3–95.6 | 94.4 | 89.5–97.2 | 0.4 | 0.1–1.5 | 0.236 |
| CMV | 96.9 | 82.9–100.0 | 96.9 | 92.7–99.0 | 1.0 | 0.1–8.9 | 1.000 |
| PV-B19 | 31.3 | 17.8–48.7 | 35.6 | 28.6–43.3 | 0.8 | 0.4–1.8 | 0.635 |
| C. trachomatis | 46.9 | 30.9–63.6 | 48.1 | 40.5–55.8 | 0.9 | 0.4–2.0 | 0.897 |
| B. pertussis | 56.3 | 39.3–71.9 | 59.4 | 51.8–66.7 | 0.9 | 0.4–1.9 | 0.742 |
| T. pallidum | 0.0 | 0.0–9.3 | 1.3 | 0.0–4.7 | 0.9 | 0.0–20.8 | 1.000 |
| T. gondii | 53.1 | 36.5–69.1 | 58.7 | 51.0–66.1 | 0.8 | 0.4–1.7 | 0.556 |
a
CI, confidence interval.
b
Data represent results from bivariate comparisons.
c
In conditional logistic regression analyses, odds ratios were as follows: ZIKV (P = 0.030; odds ratio, 4.0 [95% CI, 1.1 to 14.1]) and CHIKV (P = 0.084; odds ratio, 2.8 [95% CI, 0.1 to 9.2]).
d
Data were calculated using χ2 tests and Fisher’s exact tests when any cell count was below 5. Bold type denotes statistical significance.